Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 46, 2006, Pages 17414-17419

  Beeton, Christine ^a   Wulff, Heike ^b   Standifer, Nathan E ^c   Azam, Philippe ^b   Mullen, Katherine M ^d   Pennington, Michael W ^e   Kolski Andreaco, Aaron ^a   Wei, Eric ^a   Grino, Alexandra ^a   Counts, Debra R ^f   Wang, Ping H ^a   LeeHealey, Christine J ^a   Andrews, Brian S ^a   Sankaranarayanan, Ananthakrishnan ^b   Homerick, Daniel ^b   Roeck, Werner W ^a   Tehranzadeh, Jamshid ^a   Stanhope, Kimber L ^b   Zimin, Pavel ^b   Havel, Peter J ^b   Griffey, Stephen ^b   Knaus, Hans Guenther ^g   Nepom, Gerald T ^c   Gutman, George A ^a   Calabresi, Peter A ^d   Chandy, K George ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e Bachem Holding AG   (Switzerland)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Effector memory T cell; Rheumatoid arthritis; Type 1 diabetes mellitus

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.3; PRISTANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CALCIUM SIGNALING; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MEMORY T LYMPHOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; FEMALE; HUMANS; KV1.3 POTASSIUM CHANNEL; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; RATS; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 33751232672     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0605136103     Document Type: Article

References (42)

1. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L (2000) Nat Med 1176-1182.
2. Bielekova B, Goodin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, et al. (2000) Nat Med 6:1167-1175.
3. Klareskog L, Gaubitz M, Rodriguez-Valverde V, Malaise M, Dougados M, Wajdula J (March 15, 2006) Ann Rheum Dis, 10.1136/ard.2005.038349.
4. Goffe B, Papp K, Gratton D, Krueger GG, Darif M, Lee S, Bozic C, Sweetser MT, Ticho B (2005) Clin Ther 27:1912-1921.
5. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, et al. (2002) N Engl J Med 346:1692-1698.
6. Herzyk DJ, Gore ER, Polsky R, Nadwodny KL, Maier CC, Liu S, Hart TK, Harmsen AG, Bugelski PJ (2001) Infect Immun 69:1032-1043.
7. Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M (2006) J Clin Invest 116:1371-1381.
8. Naik RG, Beckers C, Wentwoord R, Frenken A, Duinkerken G, Brooks-Worrell B, Schloot NC, Palmer JP, Roep BO (2004) J Autoimmun 23:55-61.
9. Ott PA, Herzog BA, Quast S, Hofstetter HH, Boehm BO, Tary-Lehmann M, Durinovic-Bello I, Berner BR, Lehmann PV (2005) Clin Immunol 115:102-114.
10. Wulff H, Calabresi P, Allie R, Yun S, Pennington MW, Beeton C, Chandy KG (2003) J Clin Invest 111:1703-1713.
11. Viglietta V, Kent SC, Orban T, Hafler DA (2002) J Clin Invest 109:895-903.
12. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R (2001) J Clin Invest 108:1185-1194.
13. Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Gao L, et al. (2005) Proc Natl Acad Sci USA 102:11094-11099.
14. Pinkse G, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO (2005) Proc Natl Acad Sci USA 102:18425-18430.
15. Ellis C, Krueger GG, Alefacept Clinical Study Group (2001) N Engl J Med 345:248-255.
16. Rinaldi L, Gallo P, Calabrese M, Ranzato F, Luise D, Colavito D, Motta M, Guglielmo A, Del Giudice E, Romualdi C, et al. (2006) Brain 129:1993-2007.
17. DeCoursey TE, Chandy KG, Gupta S, Cahalan MD (1984) Nature 307:465-468.
18. Wulff H, Koppenhofer E, Hansel W (1998) Curr Res Ion Channel Modulators 3:207-212.
19. Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington MW, Bernard D, Cahalan MD, Chandy KG, Beraud E (2001) Proc Natl Acad Sci USA 98:13942-13947.
20. Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, Khaytin I, Calabresi PA, Chen C-Y, Gutman GA, et al. (2005) Mol Pharmacol 67:1369-1381.
21. Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hansel W, Wulff H (2005) Mol Pharmacol 68:1254-1270.
22. Panyi G, Vamosi G, Bacso Z, Bagdany M, Bodnar A, Varga Z, Gaspar R, Matyus L, Damjanovich S (2004) Proc Natl Acad Sci USA 101:1285-1290.
23. Szigligeti P, Neumeier L, Duke E, Chougnet C, Takimoto K, Molleran Lee S, Filipovich AH, Conforti L (2006) J Physiol 573:357-370.
24. Ishida Y, Chused TM (1993) J Immunol 151:610-620.
25. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D, Jr, Cunningham P, et al. (1997) J Immunol 158:5120-5128.
26. Lewis RS, Cahalan MD (1988) Science 239:771-775.
27. Beeton C, Chandy KG (2005) Neuroscientist 11:550-562.
28. Lange F, Bajtner E, Rintisch C, Nandakumar KS, Sack U, Holmdahl R (2005) Ann Rheum Dis 64:599-605.
29. Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, Holmdahl R (2006) J Immunol 176:1172-1179.
30. Gomez-Reino JJ, Carmona L, BIOBADASER Group (2006) Arthritis Res Ther 8:R29.
31. Ellerman K, Like AA (1995) J Exp Med 182:923-930.
32. Awata T, Guberski DL, Like AA (1995) Endocrinology 136:5731-5735.
33. Beck JC, Goodner CJ, Wilson C, Wilson DB, Glidden D, Baskin DG, Lernmark A, Braquet P (1991) Autoimmunity 9:225-235.
34. Sadelain MW, Qin HY, Sumoski W, Parfrey N, Singh B, Rabinovitch A (1990) J Autoimmun 3:671-680.
35. Like AA, Guberski DL, Butler L (1986) J Immunol 136:2354-2358.
36. Li Y, Wang P, Xu J, Desir GV (2006) Am J Physiol 290:C345-C351.
37. Chandy KG, Wulff H, Beeton C, Pennington MW, Gutman GA, Cahalan MD (2004) Trends Pharmacol Sci 25:280-289.
38. Vieira JL, Midio AF (2001) Ther Drug Monit 23:612-615.
39. Esamai F, Tenge CN, Ayuo PO, Ong'or WO, Obala A, Jakait B (2005) J Trop Pediatr 51:17-24.
40. Gottlieb AB, Casale TB, Frankel E, Goffe B, Lowe N, Ochs HD, Roberts JL, Washenik K, Vaishnaw AK, Gordon KB (2003) J Am Acad Dermatol 49:816-825.
41. Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT (2004) Diabetes 53:971-977.
42. Masewicz SA, Kochik SA, Reijonen H, Nepom GT (2004) Eur J Immunol 34:3337-3345.